 |
|
Microbiome and metabolomics in alcoholic liver disease
Raja Ganesan, Ki Tae Suk
Clin Mol Hepatol. 2022;28(3):580-582. Published online 2022 Jul 1 DOI: https://doi.org/10.3350/cmh.2022.0171
|
|
Citations to this article as recorded by
 Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease
Raja Ganesan, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Sang Hak Han, Young Joo Yang, Gwang Ho Baik, Chang Seok Bang, Dong Joon Kim, Ki Tae Suk
Hepatology International.2024; 18(2): 486. CrossRef Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury
Zufeng Wang, Chengliang Luo, Edward W. Zhou, Aaron F. Sandhu, Xiaojing Yuan, George E. Williams, Jialu Cheng, Bharati Sinha, Mohammed Akbar, Pallab Bhattacharya, Shuanhu Zhou, Byoung-Joon Song, Xin Wang
International Journal of Molecular Sciences.2023; 24(10): 8805. CrossRef Therapeutic Potential of Human Microbiome-Based Short-Chain Fatty Acids and Bile Acids in Liver Disease
Raja Ganesan, Ki Tae Suk
Livers.2022; 2(3): 139. CrossRef Diagnostic and molecular portraits of microbiome and metabolomics of short-chain fatty acids and bile acids in liver disease
Raja Ganesan, Ki Tae Suk
Process Biochemistry.2022; 123: 70. CrossRef
|